AmyeJ.TevaarwerkMD(She/Her)

PubMed

• 60 citations
  Chromosomal instability sensitizes patient breast tumors to multipolar divisions induced by paclitaxel
  Christina M. Scribano, Jun Wan, Karla Esbona, John B. Tucker, Amber Lasek
  Science Translational Medicine. 2021-09-08
• 265 citations
  Cytotoxicity of paclitaxel in breast cancer is due to chromosome missegregation on multipolar spindles
  Lauren M. Zasadil, Kristen A. Andersen, Dabin Yeum, Gabrielle B. Rocque, Lee G. Wilke
  Science Translational Medicine. 2014-03-26
• 86 citations
  Disparities in Telemedicine Access: A Cross-Sectional Study of a Newly Established Infrastructure during the COVID-19 Pandemic.
  Vivian Hsiao, Thevaa Chandereng, Robin L Lankton, Jeffrey A Huebner, Jeffrey J Baltus
  Applied Clinical Informatics. 2021-05-01

Journal Articles

• Survivor and Clinician Assessment of Survivorship Care Plans for Hematopoietic Stem Cell Transplant Patients: An Engineering, Primary Care, and Oncology Collaborative ...  
  Morken CM, Tevaarwerk AJ, Swiecichowski AK, Haine JE, Williams ZT, Norslien K, Arroyo N, Zhang X, Campbell B, Mendonca EA, Juckett MB, Sesto ME, Biol Blood Marrow Transplant, 1/11/2019
• Impact of Survivorship Care Plans and Planning on Breast, Colon and Prostate Cancer Survivors in a Community Oncology Practice  
  Hua A, Sesto Me, Zhang X, Wassenaar TR, Tevaarwerk AJ, J Cancer Educ, 1/4/2019
• Continued Challenges to the Adoption and Implementation of Survivorship Care Plans  
  Tevaarwerk AJ, Sesto ME, J Oncol Pract, 1/1/2018
• Integrating Survivorship Care Planning in Radiation Oncology Workflow  
  Huenerberg KJ, Anderson BM, Tevaarwerk AJ, Neuman HB, Wilke LG, Seaborne LA, Sesto M, JCSO, 1/1/2018
• Double-Blind Phase III Trial of Adjuvant Chemotherapy With and and hout Bevacizumab in Patients With Lymph Node-Positive and High-Risk Lymph Node-Negative Breast Cance...  
  Miller KD, O'Neill A, Gradishar W, Hobday TJ, Goldstein LJ, Mayer IA, Bloom S, Brufsky AM, Tevaarwerk AJ, Sparano JA, Le-Lindqwister NA, Hendricks CB, Northfelt DW, Da..., J Clin Oncol, 1/1/2018
• Accuracy and Thoroughness of Treatment Summaries Provided as Part of Survivorship Care Plans Prepared by Two Cancer Centers  
  Tevaarwerk AJ, Hocking WG, Zeal JL, Gribble M, Seaborne L, Buhr KA, Wisinski KB, Burkard ME, Wiegmann DA, Sesto ME, J Oncol Pract, 1/21/2017
• The impact of a primary care education program regarding cancer survivorship care plans: results from an engineering, primary care and oncology collaborative for survi...  
  Donohue SM, Haine JE, Li Z, Feldstein D, Trowbridge ER, Kamnetz SA, Sosman J, Wilke LG, Sesto ME, Tevaarwerk AJ, J Cancer Educ, 1/20/2017
• A Phase II Trial of Neoadjuvant MK-2206, an AKT Inhibitor, with Anastrozole in Clinical Stage II or III PIK3CA-Mutant ER-Positive and HER2-Negative Breast Cancer  
  Ma CX, Suman V, Goetz MP, Northfelt D, Burkard ME, Ademuyiwa F, Naughton M, Margenthaler J, Aft R, Gray R, Tevaarwerk A, Wilke L, Haddad T, Moynihan T, Loprinzi C, Hie..., Clin Cancer Res, 1/15/2017
• Cancer Survivorship Care Plan Utilization and Impact on Clinical Decision-Making at Point of-Care Visits with Primary Care: Results from an Engineering, Primary Care, ...  
  Donohue S, Haine JE, Li Z, Feldstein DA, Micek M, Trowbridge ER, Kamnetz SA, Sosman JM, Wilke LG, Sesto ME, Tevaarwerk AJ, J Cancer Educ, 1/2/2017
• Phase 1b study of orteronel in postmenopausal women with hormone-receptor positive (HR+) metastatic breast cancer  
  Rampurwala M, Wisinski KB, Burkard M, Ehsani S, O�Regan R, Carmichael L, Kim K, Kolesar J, Tevaarwerk AJ, Invest New Drugs, 1/1/2017
• Work-related barriers, facilitators, and strategies of breast cancer survivors working during curative treatment  
  Sun W, Chen K, Terhaar A, Wiegmann DA, Heidrich SM, Tevaarwerk AJ, Sesto ME, Work: A Journal of Prevention, Assessment and Rehabilitation, 1/1/2016
• Oncologists' Perceived Barriers to an Expanded Role for Primary Care in Breast Cancer Survivorship Care  
  Neuman HB, Jacobs EA , Steffens NM, Jacobson N, Tevaarwerk A, Wilke LG, Tucholka J, Greenberg CC, Cancer Med, 1/1/2016
• Targeting Estrogen Receptor Beta in a Phase 2 Study of High-Dose Estradiol in Metastatic Triple-Negative Breast Cancer: A Wisconsin Oncology Network Study  
  Wisinski KB, Xu W, Tevaarwerk AJ, Saha S, Kim K, Traynor A, Dietrich L, Hegeman R, Patel D, Blank J, Harter J, Burkard ME, Clin Breast Cancer, 1/1/2016
• Phase 1 study of an AKT-inhibitor (MK-2206) combined with lapatinib in adult solid tumors following by dose-expansion in advanced HER2+ breast cancer  
  Wisinski KB, Tevaarwerk AJ, Burkard ME, Rampurwala M, Eickhoff J, Bell MC, Kolesar JM, Flynn C, Liu G, Clin Cancer Res, 1/1/2016
• Working after a metastatic cancer diagnosis: Factors affecting employment in the metastatic setting from ECOG-ACRIN�s Symptom Outcomes and Practice Patterns study  
  Tevaarwerk AJ, Lee, JW, Terhaar A, Sesto ME, Smith ML, Cleeland C, Fisch M, Cancer, 1/1/2016
• Oncologists' Perspectives of their Roles and Responsibilities during Multi-disciplinary Breast Cancer Follow-up  
  Neuman HB, Steffens NM, Jacobson N, Tevaarwerk A, Anderson B, Wilke LG, Greenberg CC, Ann Surg Oncol, 1/1/2016
• Breast Cancer Survivor Advocacy at a University Hospital: Development of a Peer Support Program with Evaluation by Patients, Advocates and Clinicians  
  Mirriless JA, Breckheimer KR, White TW, Denure DA, Schroeder MM, Gaines ME, Wilke LG, Tevaarwerk AJ, J Cancer Educ, 1/19/2015
• Evaluating Primary Care Providers' Views on Survivorship Care Plans Generated by an Electronic Health Record System  
  Donohue SM, Sesto ME, Hahn DL, Buhr KA, Jacobs EA, Sosman JM, Andreason M, Wiegmann DA, Tevaarwerk AJ, J Oncol Pract, 1/1/2015
• Potential Cytochrome P450 Drug-Drug Interactions in Adults with Metastatic Solid Tumors and the Impact on Eligibility for Phase I Clinical Trials  
  Wisinski KB, Cantu C, Eickhoff J, Osterby K, Tevaarwerk AJ, Heidemann J, Liu G, Wilding G, Johnston S, Kolesar J, Am J Health Syst Pharm, 1/1/2015
• Treatment Differences between Urban and Rural Women with Hormone Receptor-Positive Early Stage Breast Cancer based on 21-gene Assay Recurrence Score Results  
  Andreason M, Zhang, Chong C, Onitilo AA, Engel J, Ledesma WM, Ridolfi K, Kim KM, Charlson, JC, Wisinski KB, Tevaarwerk AJ, J Community Support Oncol, 1/1/2015
• Screening magnetic resonance imaging recommendations and outcomes in patients at high risk for breast cancer  
  Ehsani S, Strigel RM, Pettke E, Wilke LG, Tevaarwerk AJ, DeMartini W, Wisinski KB, Breast J, 1/1/2015
• A multicenter phase 1 study of gamma -secretase inhibitor RO4929097 in combination with capecitabine in refractory solid tumors  
  LoConte NK, Razak AR, Ivy P, Tevaarwerk A, Leverence R, Kolesar J, Siu L, Lubner SJ, Mulkerin DL, Schelman WR, Deming DA, Holen KD, Carmichael L, Eickhoff J, Liu G., Invest New Drugs, 1/1/2015
• Phase III comparison of tamoxifen versus tamoxifen plus ovarian function suppression in premenopausal women with node-negative, hormone receptor-positive breast cancer...  
  Tevaarwerk AJ, Wang M, Zhao F, Fetting JH, Cella D, Wagner LI, Martino S, Ingle JN, Sparano JA, Solin LJ, Wood WC, Robert NJ, J Clin Oncol, 1/10/2014
• Leveraging electronic health record systems to create and provide electronic cancer survivorship care plans: a pilot study  
  Tevaarwerk AJ, Wisinski KB, Njiaju ON, Tun M, Donohue SM, Sehkon N, Yen T, Wiegman DA, Sesto ME, J Oncol Pract, 1/1/2014
• Development and Evaluation of a Survey to Assess Survivor Knowledge Change After Survivorship Care Plans: WiSDOM-B (Wisconsin Survey of cancer DiagnOsis and Management...  
  Rocque GB, Wisinski KB, Buhr KA, Froeschner JL, Jones N, Donohue S, Wiegmann D, Sesto ME, Tevaarwerk AJ, J Cancer Educ, 1/1/2014
• Join now to see all

Books/Book Chapters

• The Breast 
  Chapter: Endocrine Therapy for Breast Cancer 
  O'Regan R, Tevaarwerk AJ, Wisinski KBEditors: Kirby I. Bland and Edward M. Copeland and V. Suzanne Klimberg and William J Gradishar.ElsivierEdition 5th,2017
• Health Services for Cancer Survivors: Practice, Policy and Research 
  Chapter: Human Factors Engineering: Targeting Systems for Change 
  Page 329 - 352Sesto, M.E., Tevaarwerk, A.J., & Wiegmann, D.AEditors: Feuerstein M, Ganz PA.Edition 1st,2011

Abstracts/Posters

• Spouse depression and patient-reported outcomes: embracing complexity through understanding cancer patient and spouse dynamics
  Litzelman L, Keller A, Tevaarwerk A, DuBenske L, ISOQOL 24th Annual Conference, Philadelphia, PA, 1/1/2017
• Cancer survivorship care plan (SCP) impact on clinical decision making at point-of-care visits with Primary Care Providers (PCPs) at the University of Wisconsin (UW)
  Donohue SM, Haine JM, Trowbridge ER, Kamnetz SA, Feldstein D, Sosman J, LI Z, Wilke LG, Sesto M, Micek M, Tevaarwerk AJ, SGIM, 1/1/2017
• A primary care education program regarding cancer survivorship care plans at the University of Wisconsin (UW)
  Haine JM, Trowbridge ER, Kamnetz SA, Feldstein D, Wilke LG, Donohue SM, Sesto M, Tevaarwerk AJ, Cancer Survivorship Symposium, 1/1/2017
• Prospective Study of Work Limitations in Cancer Patients (pts) Undergoing Curative Chemotherapy (CT)
  Tevaarwerk, A et al, Cancer Survivorship Symposium, 1/1/2017
• Prospective Study of Work Limitations in Breast Cancer Patients (pts) Undergoing Curative Chemotherapy (CTx)
  Tevaarwerk, A et al, San Antonio Breast Cancer Symposium, San Antonio, TX, 1/1/2016
• What is the impact of treatments received for MBC on the ability to perform activities of daily living, symptom burden, and productivity?
  Tevaarwerk A, Reyes CM, Goertz HP, Smith ML, Bajaj PS, Railey E, Lalla D, Annual ASCO Meeting; J Clin Oncol, 1/1/2016
• What is the Health-Related Quality of Life for Women with Metastatic Breast Cancer (MBC)?
  Lalla D, Tevaarwerk A, Goertz HP, Smith ML, Bajaj P, Railey E, Reyes C, ASCO Quality Care Symposium; J Clin Oncol, 1/1/2016
• Evaluation of electronic care plan usage and usefulness among breast cancer survivors
  Sesto M, Hocking WG, Wiegmann DA, Yen TY, Gribble M, Zeal J, Koehn T, Sun W, Tevaarwerk A, Cancer Survivorship Symposium: Advancing Care and Research; J Clin Oncol, 1/1/2016
• Completeness and accuracy of survivorship care plans (SCPs) prepared via two methods: electronic health record (EHR) auto-population versus manual data entry
  Tevaarwerk A, Zeal J, Gribble M, Buhr KA, Wiegmann D, Koehn T, Sesto ME, Hocking WG, Cancer Survivorship Symposium: Advancing Care and Research; J Clin Oncol, 1/1/2016
• Developing electronic health record (EHR)-based program to deliver survivorship care plans (SCPs) and visits at the UW Breast Center
  Seaborne LA, Hueneberg K, Bohler A, Schroeder G, White T, Sesto ME, Haine J, Wilke LG, Neuman HB, Tevaarwerk AJ, Cancer Survivorship Symposium: Advancing Care and Research; J Clin Oncol, 1/1/2016
• E2112: Randomized phase III trial of endocrine therapy plus entinostat/placebo in patients with hormone receptor-positive advanced breast cancer
  Connolly RM, Zhao F, Miller K, Tevaarwerk A, Wagner LI, Lee MJ, Murray J, Gray RJ, Piekarz R, Zujewski JA, Sparano JA, ASCO annual meeting; J Clin Oncol, Chicago, IL, 1/1/2015
• Breast Cancer Survivorship Programming at Four NCI Designated Cancer Centers: Our Experiences and Lessons Learned
  Klemp JR, Sanft TB, Blaes AH, Sesto ME, Tevaarwerk A, ASCO annual meeting, Chicago, IL, 1/1/2015
• A phase II neoadjuvant trial of MK-2206, an AKT inhibitor, in combination with anastrozole for clinical stage 2 or 3 PIK3CA mutant estrogen receptor positive HER2 nega...
  Ma CX, Suman VJ, Goetz M, Northfelt D, Burkard M, Ademuyiwa F, Naughton M, Margenthaler J, Aft R, Ati SS, Vij K, Gray R, Tevaarwerk A, Wilke LG, Haddad T, Moynihan T..., San Antonio Breast Cancer Symposium, San Antonio, TX, 1/1/2015
• Usage data to evaluate web-based health interventions
  Andrea Chinchilla, Thomas Y. Yen, Douglas A. Wiegmann, Amye J. Tevaarwerk, Mary E. Sesto, Symposium on Human Factors and Ergonomics in Healthcare, Chicago, IL, 1/1/2014
• Breast cancer survivor advocacy at the University of Wisconsin Breast Center
  Mirrielees JA, Wilke LW, Breckheimer KR, White TA, DeNure DA, Schroeder MS, Tevaarwerk AJ, San Antonio Breast Cancer Symposium, San Antonio, TX, 1/1/2014
• A Phase I Study of MK-2206 in Combination with Lapatinib in Patients with Advanced Solid Tumors
  Nazeef M, Tevaarwerk AJ, Eickhoff J, Burkard ME, Heideman J, Liu G, Flynn C, Kolesar JM, Wisinski KB, San Antonio Breast Cancer Symposium, San Antonio, TX, 1/1/2014
• Randomized clinical trial assessing the impact of survivorship care plans on survivor knowledge
  Tevaarwerk AJ, Buhr KA, Wisinski KB, Burkard ME, Gribble M, Hocking W, Sun W, Donohue SM, Zeal J, Terhaar A, Wiegman DA, Sesto ME, San Antonio Breast Cancer Symposium, San Antonio, TX, 1/1/2014
• Work status of individuals with advanced cancer
  Terhaar A, Lee JW, Tevaarwerk AJ, Sesto ME, Wiegmann, DA, Fisch M, Proc Hum Factors Ergon, 1/1/2014
• Steroid hormone receptor imaging for breast cancer patients - a clinical trials update
  Fowler AM, Tevaarwerk AJ, Burnside ES, DeMartini WB, Perlman S, 6th Great Lakes Nuclear Receptor Conference, 1/1/2014
• Primary care provider (PCP) views on survivorship care plans (SCPs) generated by an electronic health record (EHR)
  Donohue S, Sesto M, Hahn D, Buhr K, Zeal J, Koehn T, Wiegmann D, Tevaarwerk A, ASCO Quality Care Symposium; J Clin Oncol, Boston, MA, 1/1/2014
• Phase 1b study of orteronel in postmenopausal women with hormone-receptor positive (HR+) metastatic breast cancer
  Rampurwala MM, Burkard ME, Wisinski KB, Chimeh SE, Zeal J, Koehn T, Champeny TL, Rettig J, Kim KM, Kolesar J, Tevaarwerk A, J Clin Oncol; ASCO Annual Meeting, 1/1/2014
• Factors associated with loss of employment among metastatic patients
  Tevaarwerk A, Lee JW, Sesto ME, Terhaar A, Smith ML, Cleeland CS, Wagner LI, Fisch M, J Clin Oncol; ASCO Annual Meeting, 1/1/2014
• Bevacizumab (Bv) in the adjuvant treatment of HER2-negative breast cancer: Final results from Eastern Cooperative Oncology Group E5103
  Miller K, O'Neill AM, Dang CT, Northfelt DW, Gradishar WJ, Goldstein LJ, Mayer IA, Brufsky A, Bloom SH, Sparano JA, Tevaarwerk A, Fox KR, Hendricks CB, Balcueva EP, Sl..., J Clin Oncol; ASCO Annual Meeting, 1/1/2014
• Cytochrome P450 interacting medication use in adult advanced solid tumor
  Wisinski KB, Cantu CA, Eickhoff JE, Osterby K, Tevaarwerk A, Liu G, Wilding G, Johnston S, Kolesar J, J Clin Oncol; ASCO Annual Meeting, 1/1/2014
• Care Coordination Models applied to Cancer Survivorship
  Kuehn et al, Symposium on Human Factors and Ergonomics in Healthcare, Chicago, IL, 1/1/2014
• Join now to see all

Lectures

• Coordinating Care for Cancer Survivors: Bridging the Gap Between Oncology and Primary Care 
  1/1/2019
• Shaping the Future: Late and Long-Term Health Considerations and Management Strategies for Young Cancer Survivors 
  UW Carbone Cancer Center, Madison, WI - 1/1/2018
• Title TBD 
  Madison, WI - 1/29/2017
• Brainstorming and collaboration: key issues and knowledge gaps of cancer survivorship care programs 
  1/1/2017
• "Help! I just saw a breast cancer survivor�." 
  Middleton, WI - 1/19/2016
• Leveraging the EHR in Cancer Survivorship 
  Verona, WI - 1/15/2016
• Overview of Late and Long-term Side Effects 
  1/12/2016
• Improving Rehabilitation of Cancer Survivors through Human Factors Engineering Collaboration with Health Care 
  Chicago, IL - 1/2/2016
• Electronic Medical Records (EMRs): Help or Hindrance in Communication between Providers? 
  1/1/2016
• The EMR: Help or Hindrance in Communication Between Providers; General Session 4: Communication and Coordination of Survivorship Care 
  1/1/2016
• Cancer Transitions 
  1/29/2015
• Breast Cancer 101 
  1/1/2015
• The Treatment of HER2+ Breast Cancer: Adjuvant and Metastatic Disease 
  1/1/2015
• Improving Quality and Safety through Human Factors Collaborations with Healthcare: The Systems Engineering Initiative for Patient Safety 
  Chicago, IL - 1/30/2014
• (UGM222) Planting the Seeds of Electronic Survivorship Care Plans 
  Verona, WI - 1/17/2014
• What Comes Next: What to know and follow after primary treatment for breast cancer 
  Madison, WI - 1/1/2014
• Cancer Survivorship Care Plans and Lessons Learned Using a Human Factors Engineering Approach 
  1/1/2014
• Survivorship Care Plan: Improving the communication Gap Between Oncology, Primary Care and Cancer Survivor? 
  Boston, MA - 1/1/2014
• Survivorship Care Plans: Improving the Communication Gap Between Oncology, Primary Care and Cancer Survivor? 
  1/1/2013
• Work Disability Prevention and Integration, Healthy Ageing in a Working Society 
  University Medical Center, Groningen, The Netherlands - 1/22/2012
• Breast Cancer: Screening, Diagnosis Etc 
  1/16/2012
• Advanced Breast Cancer 
  1/15/2012
• Cancer Survivorship Janesville/Mercy Hospital Tumor Board 
  Beloit Hospital, Beloit, WI - 1/10/2012
• "Cancer Survivorship": Where are we now and where are we going? 
  1/1/2012
• For the long haul: Side effects and followup 
  Gilda's Club, Madison, WI - 1/1/2012
• Join now to see all

Other

• Genetic Risk of Breast Cancer 
  Tevaarwerk A, TV-3 interview with Charlotte Deleste
  1/1/2007